The invention relates to medicaments for treating cardiac power failure. Saidmedicaments contain a therapeutically effective quantity of one or more S100protein(s) or one or more mutant or fragments of the same, or contain one ormore nucleic acid sequence(s) which code(s) for these amino acid sequences andwhich are optionally integrated in one or more gene transfer vectors.
展开▼